Burt Wealth Advisors’s Amedisys AMED Stock Holding History

Burt Wealth Advisors’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-100	Closed	-$6K	–	352
2017 Q2	$6K	Buy	+100	New	+$5.82K	﹤0.01%	322

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Burt Wealth Advisors's AMED Position: Q3 2017 in Review

Burt Wealth Advisors sold out of Amedisys (AMED) in Q3 2017, closing a stake of 100 shares — an estimated $6K sold.

Burt Wealth Advisors first reported a position in AMED in Q2 2017 and held it in 1 quarter. The position peaked at $6K in Q2 2017. 163 funds tracked by Wall St. Rank hold AMED as of Q3 2017.

Burt Wealth Advisors reported no remaining Amedisys position as of Q3 2017 after selling out during the quarter.
Burt Wealth Advisors sold 100 Amedisys shares in Q3 2017, an estimated $6K.
Burt Wealth Advisors first reported a position in Amedisys in Q2 2017 and held it in 1 quarter.
Burt Wealth Advisors's Amedisys position peaked at $6K in Q2 2017.
163 funds tracked by Wall St. Rank held Amedisys as of Q3 2017.

Based on Burt Wealth Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.